Radcliffe Capital Management’s Healthcare Services Acquisition Corporation Warrant HCARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-125,000
Closed -$1.24M 1004
2022
Q3
$1.24M Hold
125,000
0.03% 840
2022
Q2
$1.23M Hold
125,000
0.03% 892
2022
Q1
$1.23M Hold
125,000
0.03% 880
2021
Q4
$1.22M Hold
125,000
0.03% 769
2021
Q3
$1.22M Hold
125,000
0.04% 652
2021
Q2
$1.21M Hold
125,000
0.04% 679
2021
Q1
$1.21M Buy
+125,000
New +$154K 0.05% 544

Radcliffe Capital Management's HCARW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Healthcare Services Acquisition Corporation Warrant (HCARW) in Q4 2022, closing a stake of 125,000 shares — an estimated $1.24M sold.

Radcliffe Capital Management first reported a position in HCARW in Q1 2021 and held it in 7 quarters. The position peaked at $1.24M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCARW as of Q4 2022.

  • Radcliffe Capital Management reported no remaining Healthcare Services Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 125,000 Healthcare Services Acquisition Corporation Warrant shares in Q4 2022, an estimated $1.24M.
  • Radcliffe Capital Management first reported a position in Healthcare Services Acquisition Corporation Warrant in Q1 2021 and held it in 7 quarters.
  • Radcliffe Capital Management's Healthcare Services Acquisition Corporation Warrant position peaked at $1.24M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.